Home
Contact Us
About Pharm·ology
Founded in 2025 by Christoffer Wenzel Tornøe, PhD, Pharm·ology brings together over 20 years of drug development leadership experience.
I am a tenured leader in Clinical Drug Development, Regulatory Affairs, and Portfolio Management, with a core strength of combining cutting-edge data science, scientific depth, strategic and operational clinical development execution, and regulatory strategy.
Most recently, I served as Corporate Project Vice President for Obesity & MASH portfolio at Novo Nordisk, where I spearheaded efforts to accelerate clinical development timelines, led strategic execution for the global obesity franchise, and chaired integration of Inversago Pharma acquisition.
Prior to joining Novo Nordisk, I served as Pharmacometrics Team Leader and Reviewer at the U.S. Food & Drug Administration, learning regulatory sciences from inside a regulatory agency which complements my deep industry drug development experience.
My commitment
I believe the best drug development decisions come from combining rigorous science, robust evidence and a genuine desire to bring innovative medicines fast to patients who will ultimately benefit from your innovation.
"I am passionate about transforming drug development through quantified decision-making"
Why Choose Pharm·ology
The Pharm·ology Advantage
AI-Powered Intelligence
Our proprietary QD platform leverages artificial intelligence to synthesize evidence from multiple sources, identifying patterns and opportunities that human analysis alone might miss.
Industry-Leading Expertise
Industry-leading regulatory and clinical drug development experience.
I have been in your position and understand the decisions you need to make.
Proven ROI
Clients using our strategic consulting and QD platform have reduced development timelines, differentiated their offering and optimized regulatory strategies.
Every day saved is value created for patients and stakeholders.
Pharm·ology ApS
contact@pharmology.dk
CVR: 45557898